Estrogen reduction by aromatase inhibition for benign prostatic hyperplasia : results of a double-blind, placebo-controlled, randomized clinical trial using two doses of the aromatase-inhibitor atamestane. Atamestane Study Group

• RADLMAIER A

収録刊行物

• Prostate

  Prostate 29 199-208, 1996

詳細情報

• CRID: 1572543025260301696
• NII論文ID: 10018692778
• データソース種別:
  • CiNii Articles